Wolverine Trading
LABU icon

Wolverine Trading’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Wolverine Trading’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,242
Closed -$431K – 5204
2025
Q1 		$431K Sell
6,242
-17,479
-74% -$1.49M ﹤0.01% 3135
2024
Q4 		$2.12M Buy
23,721
+21,401
+922% +$2.52M ﹤0.01% 1911
2024
Q3 		$294K Sell
2,320
-2,982
-56% -$389K ﹤0.01% 3647
2024
Q2 		$601K Buy
+5,302
New +$568K ﹤0.01% 2669
2024
Q1 		– Sell
-2,451
Closed -$320K – 4913
2023
Q4 		$299K Buy
2,451
+1,639
+202% +$125K ﹤0.01% 3467
2023
Q3 		$61.9K Sell
812
-5,544
-87% -$569K ﹤0.01% 4138
2023
Q2 		$737K Buy
6,356
+3,474
+121% +$433K ﹤0.01% 2276
2023
Q1 		$268K Buy
2,882
+2,356
+448% +$319K ﹤0.01% 3130
2022
Q4 		$74K Sell
526
-3,115
-86% -$434K ﹤0.01% 3494
2022
Q3 		$502K Buy
+3,641
New +$667K ﹤0.01% 2602
2022
Q2 		– Sell
-6,359
Closed -$1.08M – 5168
2022
Q1 		$2.04M Buy
6,359
+1,584
+33% +$597K ﹤0.01% 1755
2021
Q4 		$3.56M Buy
4,775
+2,411
+102% +$2.31M ﹤0.01% 1386
2021
Q3 		$2.6M Buy
2,364
+1,225
+108% +$1.51M ﹤0.01% 1866
2021
Q2 		$1.69M Sell
1,139
-75
-6% -$104K ﹤0.01% 2156
2021
Q1 		$1.7M Buy
+1,214
New +$2.84M ﹤0.01% 2107
2020
Q2 		– Sell
-1,118
Closed -$516K – 4924
2020
Q1 		$516K Buy
+1,118
New +$1.02M ﹤0.01% 2622
2019
Q1 		– Sell
-526
Closed -$321K – 4926
2018
Q4 		$321K Sell
526
-1,037
-66% -$1.09M ﹤0.01% 3113
2018
Q3 		$2.91M Buy
+1,563
New +$3.07M 0.01% 1364

Other funds holding LABU

TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.37B AUM 19.43% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Trading's LABU Position: Q2 2025 in Review

Wolverine Trading sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2025, closing a stake of 6,242 shares — an estimated $431K sold.

Wolverine Trading first reported a position in LABU in Q3 2018 and held it in 18 quarters. The position peaked at $3.56M in Q4 2021. 33 funds tracked by Wall St. Rank hold LABU as of Q2 2025.

  • Wolverine Trading reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 6,242 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2025, an estimated $431K.
  • Wolverine Trading first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2018 and held it in 18 quarters.
  • Wolverine Trading's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $3.56M in Q4 2021.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.